RxDoctor Payments Data

Michael Pickert

Psychiatric/Mental Health · Irvington, ALNPI 1275090300

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,844 of the $9,690 with a category attached, or 80.9%. It is spread thinly across 24 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,690in general payments, 2019–2025

Across 365 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$2K
  • AbbVie$2K
  • Neurocrine Biosciences, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$800
  • Novartis$600
  • Otsuka America Pharmaceutical, Inc.$540
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$1,20012%
  • Speaking & faculty fees$6006%
  • Food & beverage$7,84481%
  • Education$470%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,690 in reported general payments places this provider in the 90th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide12$5,885
Vilazodone Hcl20$2,328
Quetiapine Fumarate136$2,275
Duloxetine Hcl14$1,157
Trazodone Hcl79$992
Aripiprazole22$839
Mirtazapine55$817
Doxepin Hcl23$789
Hydroxyzine Hcl35$678
Quetiapine Fumarate ErQuetiapine Fumarate17$551
Lurasidone Hcl13$539
Olanzapine28$489
Buspirone Hcl35$480
Bupropion XlBupropion Hcl18$461
Sertraline Hcl73$448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$124$5,88512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Irvington

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →